Literature DB >> 11725161

Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study.

M Matsubara1, M Kikuya, T Ohkubo, H Metoki, F Omori, T Fujiwara, M Suzuki, M Michimata, A Hozawa, T Katsuya, J Higaki, I Tsuji, T Araki, T Ogihara, H Satoh, S Hisamichi, K Nagai, H Kitaoka, Y Imai.   

Abstract

OBJECTIVE: The C-344T polymorphism in the 5'-flanking region of the aldosterone synthase (CYP11B2) gene has been suggested to be associated with hypertension and disturbed circadian blood pressure (BP) rhythm through its effect on aldosterone synthesis. However, previous findings on this topic have been inconsistent.
DESIGN: A cross-sectional study. SUBJECTS AND METHODS: We investigated the CYP11B2 C-344T genotype in 802 subjects, aged 40 and over, in a Japanese community, who gave written informed consent and were monitored for 24 h ambulatory BP.
RESULTS: The frequencies of the CC, CT, and TT genotypes in these Japanese subjects were 0.14, 0.44, and 0.42, showing a higher frequency of the T allele (0.64) than in Caucasians. Although there was no significant difference in 24 h ambulatory BP levels among the genotypes, the nocturnal decline in BP was significantly greater in the CC homozygous subjects than in other subjects (P = 0.0065 for systolic and P = 0.031 for diastolic decline in nocturnal BP). Detailed analyses demonstrated that this association was significant only in aged (60 years and over) or male subjects. The prevalence of previous cardiovascular disease was significantly less in these subjects with the CC genotype than in those with the TC and TT genotypes, although age, body mass index, male gender, smoking, use of alcohol and antihypertensive medication did not differ among the three genotypes. There was no significant difference among the three genotypes in biochemical and hormonal parameters.
CONCLUSION: Although the C-344 T polymorphism of CYP11B2 did not directly influence the level of 24 h BP, the CC genotype was associated with decreased nocturnal BP in elderly or male Japanese. Since prevalence of previous cardiovascular disease was significantly less in homozygous CC subjects, greater nocturnal BP decline in this genotype appears to be beneficial in the circadian BP rhythm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725161     DOI: 10.1097/00004872-200112000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Genetic polymorphisms in the beta-subunit of the epithelial sodium channel (βENaC) gene in the Japanese population.

Authors:  Michiko Suzuki; Tomomi Sato; Tohru Fujiwara; Mari Michimata; Tsutomu Araki; Hirohito Metoki; Masahiro Kikuya; Itsuro Kazama; Junichiro Hashimoto; Atsushi Hozawa; Takayoshi Ohkubo; Ichiro Tsuji; Yutaka Imai; Mitsunobu Matsubara
Journal:  Clin Exp Nephrol       Date:  2002-09       Impact factor: 2.801

2.  Characterization of biological pathways associated with a 1.37 Mbp genomic region protective of hypertension in Dahl S rats.

Authors:  Allen W Cowley; Carol Moreno; Howard J Jacob; Christine B Peterson; Francesco C Stingo; Kwang Woo Ahn; Pengyuan Liu; Marina Vannucci; Purushottam W Laud; Prajwal Reddy; Jozef Lazar; Louise Evans; Chun Yang; Theresa Kurth; Mingyu Liang
Journal:  Physiol Genomics       Date:  2014-04-08       Impact factor: 3.107

3.  Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy.

Authors:  E Takai; H Akita; K Kanazawa; N Shiga; M Terashima; Y Matsuda; C Iwai; Y Miyamoto; H Kawai; A Takarada; M Yokoyama
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

4.  A method to account for covariate-specific treatment effects when estimating biomarker associations in the presence of endogenous medication use.

Authors:  Andrew J Spieker; Joseph Ac Delaney; Robyn L McClelland
Journal:  Stat Methods Med Res       Date:  2016-12-22       Impact factor: 3.021

5.  GWAS of longitudinal trajectories at biobank scale.

Authors:  Seyoon Ko; Christopher A German; Aubrey Jensen; Judong Shen; Anran Wang; Devan V Mehrotra; Yan V Sun; Janet S Sinsheimer; Hua Zhou; Jin J Zhou
Journal:  Am J Hum Genet       Date:  2022-02-22       Impact factor: 11.043

Review 6.  RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease.

Authors:  Jay Lakkis; Wei X Lu; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

7.  Renal function in relation to three candidate genes in a Chinese population.

Authors:  Ji-Guang Wang; Lifang Liu; Laura Zagato; Jinxiang Xie; Robert Fagard; Kugen Jin; Jinxiang Wang; Yan Li; Giuseppe Bianchi; Jan A Staessen; Lisheng Liu
Journal:  J Mol Med (Berl)       Date:  2004-09-18       Impact factor: 4.599

8.  Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use.

Authors:  Andrew J Spieker; Joseph A C Delaney; Robyn L McClelland
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-09-30       Impact factor: 2.890

Review 9.  Hypertension in Asian/Pacific Island Americans.

Authors:  Ralph E Watson; Rudruidee Karnchanasorn; Ved V Gossain
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.